Cardiol Therapeutics Inc.

NASDAQ:CRDL

Drug Manufacturers - Specialty & Generic

Healthcare
$0.95 -0.47%

-$0.01 today

Market cap
$114.64M
Beta
0.80
P/E (TTM)
-4.5
EPS (TTM)
-$0.33
52W Low $0.88High $1.71

Volume 0.31M

Average 0.68M

CRDL Common Stock

The par or stated value of issued common shares, plus paid-in capital where reported together.

Cardiol Therapeutics Inc.NASDAQ: CRDL

Common Stock · Q1 FY2026 · quarter ended Mar 2026

Common stock rises 19.0% from a year ago

Common stock stood at CA$213.35M at the end of Q1 FY2026, up 19.0% from a year earlier and up 5.7% from the prior quarter. Over 3 fiscal years it compounded at +22.9% a year.

Context

  • Common stock amounted to 677.6% of total assets at the end of Q1 FY2026, down 27.0 pp from a year earlier.
  • Common stock increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether common stock keeps rising in the next quarterly balance sheet after a +19.0% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$213.35M+5.7% QoQ
Last fiscal yearDec 2025
CA$201.87M+12.6% YoY
Year agoMar 2025
CA$179.34M+19.0% since
Common Stock past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+19.0%——
1 year+12.6%——
3-year CAGR+22.9%——
5-year CAGR——
10-year CAGR——

Common Stock history

CAD · from the balance sheet

Latest · FY2025
201.87M CAD
Year-over-year change
+12.6%
4-year CAGR
+9.0%

Common Stock vs competitors

How CRDL compares with its peers on the latest reported figures

  • Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of +19.0% is the 4th highest of 10, against a peer median of +2.6%.
  • Common stock amounts to 677.6% of total assets for CRDL, versus a peer median of 0.0%.
CRDL Competitors
Common Stock for CRDL and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
INCRInterCure Ltd.Dec 2025₪675.6M ILS+2.6%+2.2%97.8%
CRDLCardiol Therapeutics Inc.Mar 2026CA$213.35M CAD+19.0%+22.9%677.6%
IFRXInflaRx N.V.Mar 2026€8.68M EUR+6.8%+17.4%17.7%
MBOTMicrobot Medical Inc.Mar 2026$672K USD+93.1%+103.3%0.9%
IMAImageneBio IncMar 2026$11K USD-77.1%-32.6%0.0%
HYPRHyperfine, Inc.Mar 2026$10K USD+25.0%+12.6%0.0%
CNTBConnect Biopharma Holdings LimitedDec 2025$10K USD+0.0%+0.0%0.0%
VANIVivani Medical, Inc.Mar 2026$8K USD+33.3%+17.0%0.0%
KLRSKalaris Therapeutics IncMar 2026$2K USD+0.0%—0.0%
ASRTAssertio Holdings, Inc.Mar 2026$1K USD-88.9%-41.5%0.0%
Peer median (excluding CRDL) —+2.6%+7.4%0.0%

Competitors are the stored peer set for CRDL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents83.9M43.83M34.93M30.58M21.42M
Short-term Investments045.65K000
Net Receivables65.74K354.24K279.87K361.62K226.2K
Inventory00000
Other Current Assets341.39K0000
Total Current Assets87.14M45.32M36.15M31.67M23.5M
Property, Plant & Equipment (Net)356.49K218.17K337.06K195.59K118.09K
Goodwill00000
Intangible Assets379.25K217.48K210.36K00
Long-term Investments00000
Tax Assets00000
Other Non-current Assets00000
Total Non-current Assets735.74K435.64K547.42K195.59K118.09K
Total Assets87.88M45.76M36.7M31.86M23.62M
Account Payables4.14M6.16M7.62M6.98M0
Short-term Debt037.21K000
Tax Payables00000
Deferred Revenue00000
Other Current Liabilities6.66M1.04M238.18K05.62M
Total Current Liabilities11.57M7.23M8.3M7.01M5.66M
Long-term Debt00000
Deferred Tax Liabilities00000
Deferred Revenue (Non-current)00000
Other Non-current Liabilities(0)0000
Total Non-current Liabilities72.87K16.54K158.53K125.52K87.18K
Total Liabilities11.64M7.25M8.45M7.14M5.74M
Common Stock142.92M108.84M148.52M179.34M201.87M
Retained Earnings(83.52M)(84.43M)(142.58M)(179.25M)(213.07M)
Accumulated OCI4.18M2.6M3.52M00
Other Stockholders Equity8290(666)00
Minority Interest00000
Total Equity76.24M38.51M28.25M24.73M17.88M
Total Debt117.58K53.76K174.34K158.53K125.52K
Net Debt(83.78M)(43.77M)(34.76M)(30.42M)(21.29M)

Cardiol Therapeutics Inc.

NASDAQ:CRDL

Intrinsic Alpha fair value

Locked

Current Price

$0.95

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.